Huiyu Pharmaceutical: CITIC Construction Investment Securities Co., Ltd.\'s inspection opinion on Sichuan Huiyu Pharmaceutical Co., Ltd. providing guarantees to subsidiaries and accepting guarantees from related parties
Huiyu Pharmaceutical: Announcement of Supervisory Committee Resolutions
Huiyu Pharmaceutical: Announcement on providing guarantees to subsidiaries and accepting guarantees from related parties
Huiyu Pharmaceutical: Announcement of Board Resolutions
Announcement of Supervisory Board Resolutions
CITIC Construction Investment Securities Co., Ltd.\'s inspection opinion on Sichuan Huiyu Pharmaceutical Co., Ltd. providing guarantees to subsidiaries and accepting guarantees from related parties
Announcement of Board Resolutions
Notice on providing guarantees to subsidiaries and accepting guarantees from related parties
Notice on Voluntary Disclosure of HY07121 Obtaining Drug Clinical Trial Approval Notice
Notice on Voluntary Disclosure of Methotrexate Injections Obtaining Drug Registration Certificates
Sichuan Huiyu Pharmaceutical Co., Ltd. Investor Relations Activity Record Form for September 18, 2024
Shareholders holding 5% or more of the shares expire of the reduction period and announcement of the results of centralized bidding to reduce their holdings
Notice on Voluntary Disclosure of HY-2003 Pharmaceutical Clinical Trial Application Acceptance Notice
Announcement on attending the 2024 semi-annual pharmaceutical and biological products industry collective performance briefing
Notice of voluntary disclosure of concentrated sodium valproate solution for injection to obtain marketing approval in Ireland
CITIC Construction Investment Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Sichuan Huiyu Pharmaceutical Co., Ltd.
Notice of voluntary disclosure that proxafil injections, injectable azacitidine, and injectable cetipa have obtained marketing licenses in Israel, Egypt, and Northern Ireland, respectively
Notice on Voluntary Disclosure of Cyclophosphamide for Injection to Obtain Drug Registration Certificates
Sichuan Huiyu Pharmaceutical Co., Ltd. Investor Relations Activity Record Form for August 27, 2024
2024 Semi-Annual Report
No Data
No Data